Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
Healthy Volunteers
NCT05300464

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Led by Umbria Bioengineering Technologies · Updated on 2025-01-06

600

Participants Needed

3

Research Sites

212 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a multicentric, single arm, prospective, stratified by breast density clinical investigation to confirm the ability of the microwave mammogram 'MammoWave' to detect breast lesions. MammoWave is a innovative medical device, class IIa marked CE, which uses microwaves instead of ionazing radiation (x-ray) for breast lesions. Specifically MammoWave employs a novel technique wich generates images by processing very low power (\<1mW) microwave. The MammoWave exam takes few minutes for breast and is performed with the patient lying in a confortable facing down position. MammoWave is safe to be used at any age, in any condition (pregnancy, specific illness and for unlimited number of times.

CONDITIONS

Official Title

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Who Can Participate

Age: 18Years +
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Signed Informed consent Form
  • Women
  • Adult 63 18 years old
  • Having a radiologist study output obtained using mammography within the last month. Such radiologist study output may be integrated with ultrasound and /or magnetic resonance imaging output if deemed necessary by the responsible investigator and when available. The radiological output will be integrated with histological one if deemed necessary by the responsible investigator and when available.
  • Patients willing to comply with study protocol and recommendations
Not Eligible

You will not qualify if you...

  • Patients who belong to any vulnerable group
  • Patients with implanted electronic devices
  • Patients who have undergone biopsy less than one week before MammoWave scan
  • Patients with nipple piercings (unless they are removed prior to examination)
  • Pregnancy or breastfeeding

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

IRCCS Policlinico San Martino

Genova, Genova, Italy, 16132

Actively Recruiting

2

Ospedale San Giovanni Battista - USL Umbria 2

Foligno, Perugia, Italy, 06034

Not Yet Recruiting

3

Hospital Universitario de Toledo

Toledo, Spain, Spain, 45007

Actively Recruiting

Loading map...

Research Team

G

Gianluigi Tiberi

CONTACT

S

Sabatino Tiberi

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here